By David Bronstein
Immunoglobulin (IG) treatment-related fluctuations (TRFs) can be a significant barrier to successful management of chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). Now, a multicenter team of researchers has devised a method for assessing those fluctuations: at-home grip strength tests self-administered by patients.